Nasdaq Lmat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq lmat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Lmat Today - Breaking & Trending Today

LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week High on Analyst Upgrade

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) hit a new 52-week high during trading on Monday after StockNews.com upgraded the stock from a hold rating to a buy rating. The stock traded as high as $75.99 and last traded at $75.71, with a volume of 62552 shares changing hands. The stock had […] ....

Lawrencej Jasinski , Stifel Nicolaus , Georgew Lemaitre , Lemaitre Vascular , Barrington Research , Johnson Investment Counsel Inc , Conestoga Capital Advisors , Lemaitre Vascular Inc , Vanguard Group Inc , Envestnet Asset Management Inc , Get Free Report , Director Lawrence , Asset Management , Capital Advisors , Investment Counsel , Dark Forest Capital Management , Forest Capital Management , Maitre Vascular , Lemaitre Vascular Daily , Nasdaq Lmat ,

Barrington Research Increases LeMaitre Vascular (NASDAQ:LMAT) Price Target to $79.00

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price upped by analysts at Barrington Research from $69.00 to $79.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price target would indicate a potential upside of 6.44% […] ....

Georgew Lemaitre , Josephp Pellegrino Jr , Stifel Nicolaus , Dekabank Deutsche Girozentrale , Lemaitre Vascular Inc , Whitegate Investment Counselors Inc , Barrington Research , Investment Advisors Inc , Bluepath Capital Management , Lemaitre Vascular Company Profile , Lemaitre Vascular , Capital Advisors Inc , Get Free Report , Maitre Vascular , Path Capital Management , Bank Deutsche Girozentrale , Whitegate Investment Counselors , Lemaitre Vascular Daily , Nasdaq Lmat , Boost Price Target ,

LeMaitre Vascular (NASDAQ:LMAT) PT Raised to $79.00

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price hoisted by equities researchers at Barrington Research from $69.00 to $79.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective indicates a potential upside of 6.44% from […] ....

Dekabank Deutsche Girozentrale , Josephp Pellegrino Jr , Stifel Nicolaus , Lawrencej Jasinski , Lemaitre Vascular Company Profile , Lemaitre Vascular , Capital Advisors Inc , Securities Exchange Commission , Investment Advisors Inc , Barrington Research , Bluepath Capital Management , Lemaitre Vascular Inc , Whitegate Investment Counselors Inc , Get Free Report , Maitre Vascular , Director Lawrence , Exchange Commission , Path Capital Management , Bank Deutsche Girozentrale , Whitegate Investment Counselors , Lemaitre Vascular Daily , Nasdaq Lmat , Boost Price Target ,

LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $77.00

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its price objective upped by research analysts at JMP Securities from $72.00 to $77.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “market outperform” rating on the medical instruments supplier’s stock. JMP Securities’ target price indicates a potential upside of 3.75% […] ....

Stifel Nicolaus , Lawrencej Jasinski , Dekabank Deutsche Girozentrale , Josephp Pellegrino Jr , Capital Advisors Inc , Barrington Research , Whitegate Investment Counselors Inc , Lemaitre Vascular , Bluepath Capital Management , Lemaitre Vascular Inc , Lemaitre Vascular Company Profile , Investment Advisors Inc , Securities Exchange Commission , Get Free Report , Maitre Vascular , Director Lawrence , Exchange Commission , Path Capital Management , Bank Deutsche Girozentrale , Whitegate Investment Counselors , Lemaitre Vascular Daily , Nasdaq Lmat , Boost Price Target , Jmp Securities ,

LeMaitre Vascular (NASDAQ:LMAT) Releases Earnings Results, Beats Expectations By $0.05 EPS

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.05, Briefing.com reports. LeMaitre Vascular had a net margin of 15.56% and a return on equity of 10.57%. The business had revenue […] ....

Georgew Lemaitre , Stifel Nicolaus , Lemaitre Vascular , Lemaitre Vascular Inc , Securities Exchange Commission , Barrington Research , Get Free Report , Maitre Vascular , Exchange Commission , Lemaitre Vascular Daily , Nasdaq Lmat ,